Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stem cell therapy for urinary incontinence].

H Strasser1, R Marksteiner, E Margreiter

  • 1Klinik für Urologie, Medizinische Universität, Innsbruck. hannes.strasser@uibk.ac.at

Der Urologe. Ausg. A
|November 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results and comparison of the Green-Anderson and multiplier growth prediction methods after permanent epiphysiodesis using Canale's technique.

Journal of children's orthopaedics·2019
Same author

Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014.

Andrology·2019
Same author

[Unexpected differential diagnosis of urachal cancer].

Der Urologe. Ausg. A·2018
Same author

[Urolithiasis 2016 : Reliable, effective and low radiation exposure].

Der Urologe. Ausg. A·2016
Same author

[Pediatric clubfoot : Treatment of recurrence].

Der Orthopade·2016
Same author

[Patient blood management: Current state of the literature].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2015
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Autologous stem cell injections effectively treat urinary incontinence. This novel therapy using myoblasts and fibroblasts demonstrated significant success in both animal models and human patients, offering a promising new treatment option.

Area of Science:

  • Regenerative Medicine
  • Urology
  • Cell Therapy

Background:

  • Urinary incontinence is a prevalent condition impacting quality of life.
  • Current treatments for urinary incontinence have limitations.
  • Autologous cell therapy presents a potential alternative.

Purpose of the Study:

  • To evaluate the efficacy and safety of transurethral ultrasound-guided injections of autologous myoblasts and fibroblasts for treating urinary incontinence.
  • To assess cell survival, tissue regeneration, and clinical outcomes in animal models and human patients.

Main Methods:

  • In vivo studies in female pigs to assess cell survival and tissue formation.
  • Clinical trial involving 42 patients (29 women, 13 men) with urinary stress incontinence.
  • Injection of fibroblasts with collagen into the urethral submucosa and myoblasts into the rhabdosphincter.

Related Experiment Videos

Main Results:

  • Successful survival of injected cells and formation of new muscle tissue in pigs.
  • Complete cure of urinary incontinence in 35 out of 42 patients.
  • Improvement in urinary incontinence for seven patients with complex histories (prior surgery, radiotherapy).
  • No postoperative side effects or complications observed.

Conclusions:

  • Transurethral ultrasound-guided injection of autologous myoblasts and fibroblasts is an effective treatment for urinary incontinence.
  • This cell-based therapy shows significant promise for reconstructing muscle and healing defects.
  • The findings support autologous stem cell therapy as a viable future treatment modality for urinary incontinence.